What Happens to Muscle on GLP-1s Like Ozempic GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) work by mimicking a natural hormone that slows gastric emptying, reduces appetite, and improves satiety
Among these segments, the type 2 diabetes segment is dominating the market during the forecast period due to when blood glucose levels are high, the GLP-1 receptor agonist plays a key function in boosting insulin release and inhibiting glucagon production
The window for market entry remains open partly due to persistent supply constraints among current manufacturers and partly because the addressable patient population continues expanding as clinical evidence mounts for GLP-1 benefits across obesity, diabetes, MASH, cardiovascular disease, and other indications
How treatment duration affects total spending Treatment duration determines cost escalation patterns
The FDA typically monitors the supply situation for a period after manufacturers report increased production, often 2-3 months, to ensure the shortage is truly resolved before updating the database
